releasing factor (CRF) injected peripherally induces clustered spike-burst activity in the proximal colon through CRF1 receptors in rats. We investigated the effect of intraperitoneal CRF on proximal colon ganglionic myenteric cell activity in conscious rats using Fos immunohistochemistry on the colonic longitudinal muscle/myenteric plexus whole mount preparation. In vehicle-pretreated rats, there were only a few Fos immunoreactive (IR) cells per ganglion (1.2 Ϯ 0.6). CRF (10 g/kg ip) induced Fos expression in 19.6 Ϯ 2.1 cells/ganglion. The CRF1/CRF2 antagonist astressin (33 g/kg ip) and the selective CRF1 antagonist CP-154,526 (20 mg/kg sc) prevented intraperitoneal CRF-induced Fos expression in the proximal colon (number of Fos-IR cells/ganglion: 2.7 Ϯ 1.2 and 1.0 Ϯ 1.0, respectively), whereas atropine (1 mg/kg sc) had no effect. Double labeling of Fos with protein gene product 9.5 revealed the neuronal identity of activated cells that were encircled by varicose fibers immunoreactive to vesicular acetylcholine transporter. Fos immunoreactivity was mainly present in choline acetyltransferase-IR nerve cell bodies but not in the NADPH-diaphorase-positive cells. These results indicate that peripheral CRF activates myenteric cholinergic neurons in the proximal colon through CRF 1 receptor.
CORTICOTROPIN-RELEASING FACTOR (CRF) is a 41-amino acid peptide of hypothalamic origin, initially established to be the main regulator of stress-related activation of the pituitary adrenal axis (55) . Subsequent studies established that the activation of CRF pathways in the brain also plays an important role in the behavioral, autonomic, visceral, and immune responses to stress (15, 50) . In addition, increasing evidence indicates that CRF and CRF-related peptides administered peripherally exert actions on the cardiovascular, immune, gastrointestinal, vascular, and reproductive systems that may have pathophysiological relevance (3, 18, 29, 31, 39) . In the lower gut, peripheral administration of CRF stimulates propulsive colonic motor function as shown by the increase in colonic motility, transit, and defecation in rats (7, 29, 56) . Likewise, intravenous injection of CRF increases motility in the sigmoid colon in healthy subjects and more prominently in patients with irritable bowel syndrome (10) .
The biological actions of CRF are mediated through activation of CRF 1 and CRF 2 receptors that have been cloned from two distinct genes (42) . CRF receptors belong to the seven transmembrane domain family positively coupled to adenylate cyclase via G proteins (42) . The development of peptide antagonists nonselective for CRF 1 and CRF 2 , namely ␣-helical CRF and, more recently, astressin (14) , as well as selective CRF 1 antagonists, CP-154,526 and antalarmin (11, 48) , provides tools to assess the biological role of CRF receptors. In rats, we previously reported (29) that astressin or CP-154,526 injected peripherally antagonized intraperitoneal CRF-induced clustered spike-burst activity in the proximal colon and defecation. CP-154,526 injected peripherally also alleviates water avoidance stress-induced defecation and morphine withdrawal stress-induced diarrhea in rats (28, 29) . In monkeys, oral administration of antalarmin reduced a broad range of anxiety-related biological responses to an acute social stress including urination and defecation (15) . These observations support the implication of CRF receptors, mainly CRF 1 , in the colonic motor response to acute stress. However, the mechanism(s) through which peripheral CRF stimulates colonic motility remain largely unknown (29, 30) . At the cellular level, intracellular recording of enteric neuronal activity has demonstrated that CRF applied directly on a longitudinal muscle/myenteric plexus (LMMP) preparation from guinea pig ileum excites myenteric neurons (16) . These data suggest a possible action of CRF at the level of the colonic myenteric nervous system.
The present study was undertaken to characterize the receptor-mediated action of rat/human CRF (r/hCRF) injected peripherally on the activity of myenteric cells in the rat proximal colon using c-Fos expression. Growing evidence indicates that immunohistochemical detection of Fos is a relevant approach to map enteric neuron activation in response to physiological and pathophysiological stimuli (32, 34, 43) .
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats (Harlan, San Diego, CA) weighing 250-300 g were maintained under controlled environmental conditions (12:12-h light-dark cycle, 22 Ϯ 1°C) with free access to food (Purina Rat Chow) and tap water for at least 7 days before the experiments. Rats were accustomed to single housing and handled daily for 2 days before the experiments, which were carried out between 9:00 AM and 12:00 PM. Protocols (99-127-07) were approved by the Animal Research Committee of the Veteran Affairs Greater Los Angeles Healthcare System. 33 ]-r/hCRF12-41 (Salk Institute, Clayton Foundation Laboratories for Peptide Biology, La Jolla, CA) were synthesized as previously described (14) and kept at Ϫ80°C in powder form. CRF was dissolved in sterile saline and astressin in double-distilled water and adjusted to pH 7.0 immediately before use. CP-154,526, (Pfizer, Croton, CT) was kept at room temperature and dissolved in a mixture of 5% dimethyl sulfoxide (DMSO; Sigma, St Louis, MO), 5% cremophor El (Sigma), and 90% saline before the administration as previously described (29) . Solutions were injected subcutaneously or intraperitoneally in doses of 0.25-0.3 ml/rat except otherwise mentioned.
Substances and Treatments
Experimental Protocols
Effects of intraperitoneal CRF on Fos expression in myenteric cells in vehicle-or astressin-pretreated rats. Rats (n ϭ 4-6/group) were injected intraperitoneally with either vehicle (water) or astressin (33 g/kg) 15 min before the injection of CRF (10 g/kg ip) or saline. The regimen of CRF injection was selected based on previous studies showing the induction of clustered spike-burst activity in the proximal colon and inhibition of CRF action by astressin administered at the same dose (29) .
Effects of ip CRF on Fos expression in colonic myenteric cells in vehicle-or CP 154,526-pretreated rats. Rats (n ϭ 6-9/ group) were injected subcutaneously (0.5 ml) with either vehicle (DMSO ϩ cremophor ϩ saline) or CP 154,526 (20 mg/kg) 30 min before the intraperitoneal injection of CRF (10 g/kg) or saline. The dose of CP 154,526 was previously reported to antagonize CRF (10 g/kg ip)-induced stimulation of proximal colonic motility (29) .
Effects of intraperitoneal CRF on Fos expression in colonic myenteric cells in vehicle-or atropine-pretreated rats. Rats were injected subcutaneously with vehicle (n ϭ 4) or atropine (1 mg/kg; n ϭ 3), and 30 min later, CRF (10 g/kg) was injected intraperitoneally.
In all experiments, rats were euthanized by decapitation 1 h after the intraperitoneal injection of saline or CRF. The proximal colon was immediately removed and processed for immunohistochemistry.
Tissue Preparation
Tissue preparation was performed as previously described (32, 34) . The proximal colon was opened longitudinally along the mesenteric border in PBS (pH 7.4) containing nifedipine (10 Ϫ6 M) to avoid muscle contraction. Tissue was stretched and pinned flat on a Sylgard-coated Petri dish (Sylgard 184, Dow Corning Midland, MI) and fixed overnight in Zamboni's fixative (pH 7.4) at 4°C. After fixation, the colonic tissue was washed (3 times for 10 min each) in PBS (pH 7.4), and LMMP whole mount preparations of ϳ0.25 cm 2 each were dissected and processed for immunohistochemistry (32, 34 The following chemicals were used: Triton X-100, hydrogen peroxide, and ␤-NADPH from (Sigma), Vectastain Elite ABC Kit (model PK-6100), which contains avidin and biotinylated horseradish peroxidase reagents, and the peroxidase substrate Kit DAB (diaminobenzine solution, model SK-4100) from Vector Laboratories (Burlingame, CA).
Fos immunolabeling. The immunohistochemical procedure used was previously described (32, 34) . Briefly, LMMP whole mount preparations from the proximal colon were rinsed (3 times for 10 min each) in PBS (pH 7.4) and incubated for 30 min at room temperature with PBS containing 0.3% hydrogen peroxide to remove endogenous peroxidase activity. After a further rinsing in PBS, tissues were incubated for 1 h at room temperature with normal goat serum (3%) in PBS containing 0.3% Triton X-100 to block nonspecific binding (blocking solution). Tissues were then incubated for 48 h at 4°C with a polyclonal rabbit anti-Fos (fos Ab-5, 1:10,000) diluted in the blocking solution mentioned above. After the primary antibody, tissues were rinsed (3 times for 10 min each) in PBS and incubated for 2 h at room temperature with biotinylated goat anti-rabbit secondary antibody (1:500). Finally, tissues were rinsed (3 times for 10 min each) in PBS (pH 7.4) and processed using the standard biotin-avidinhorseradish peroxidase methodology (21) . Tissues were examined using a light microscope (Zeiss Axioskop; Carl Zeiss, Thornwood, NY) and photographed (Kodak Technical Pan film). Fos immunoreactivity was also examined using indirect immunofluorescence. LMMP whole mount preparations were rinsed (3 times for 10 min each) in PBS containing 0.1% Triton X-100 (PBS-T; pH 7.4) and incubated for 1 h at room temperature with a blocking solution (3% normal goat serum in PBS containing 0.1% Triton X-100). Tissues were then incubated for 48 h at 4°C with a polyclonal rabbit anti-Fos (fos Ab-5, 1:5,000). After the first incubation, tissues were rinsed (3 times for 10 min each) in PBS-T and incubated for 1 h at room temperature with goat anti-rabbit IgG conjugated to FITC (1:50) or TRITC (1:100). All antibodies were diluted in PBS-T containing 0.1% BSA (antibody diluent). Tissues were given a final wash (3 times for 10 min each) with PBS-T, mounted in bicarbonate-buffered glycerol (pH 8.6), and examined using Zeiss LSM 510 laser scanning microscope (Carl Zeiss). Immunohistochemical controls involved incubation of tissues in blocking solution (3% normal goat serum in PBS containing 0.3% Triton X-100) followed by antibody diluent in place of primary antibody and processed as above. No positive staining was observed under these conditions. Double labeling. The double-labeling procedure was performed as previously described (34) and involved Fos immunolabeling with PGP 9.5, VChAT, ChAT, and NADPH diaphorase (NADPH-d) in the LMMP whole mount preparations from the proximal colon. PGP 9.5, a well established marker for neuronal cell bodies and axons in the central and peripheral nervous systems (23, 34) , was used to ascertain the neuronal identity of colonic myenteric cells expressing Fos. ChAT, the enzyme for acetylcholine synthesis (27, 47) , VChAT, a specific marker of cholinergic axons (2, 27) , and NADPH-d activity for histochemical detection of nitric oxide synthase (NOS) (4, 53) were used to assess the biochemical coding of cells expressing Fos.
Fos with PGP9.5, VChAT, or ChAT. Indirect immunofluorescence was used for the double labeling. LMMP whole mount preparations from the proximal colon were rinsed (3 times for 10 min each) with PBS-T (pH 7.4). After being rinsed, tissues were incubated separately for 48 h at 4°C with a monoclonal Fos antibody (TF161; 1:500) alone or combined with the following polyclonal antibodies: 1) rabbit anti-human PGP 9.5 (1:500), 2) rabbit anti-VChAT (1:500), or 3) goat anti-ChAT (1:1,000). Primary as well as secondary antibodies were mixed before use. After the first incubation, tissues were washed with PBS-T and incubated for 1 h at room temperature with donkey anti-mouse IgG conjugated to FITC (1:50) or TRITC (1:100) alone or combined to goat anti-rabbit IgG conjugated to TRITC (1:100) or FITC (1:50), or donkey anti-goat IgG conjugated to TRITC (1:100). All antibodies were diluted in antibody diluent. Tissues were given a final wash (3 times for 10 min each) with PBS-T and mounted in bicarbonate-buffered glycerol (pH 8.6). The antibodies raised against Fos (fos Ab-5 and TF161), VChAT, and ChAT have been previously used in the gut tissues (32-34, 44, 49, 57) . Controls were performed by incubating a few LMMP whole mount preparations in antibody diluent in place of the primary antibodies and processed as above. Tissues were examined using the Zeiss LSM 510 laser scanning microscope (Carl Zeiss), whose fluorescent optics with both FITC/TRITC filters allowed the dual-labeling analysis by overlapping the labeling from different primary antibodies. For each examined colonic LMMP whole mount preparation, single and/or double stainings were detected using TRITC, FITC, or FITC/ TRITC filters. Images were viewed and captured using the computerized image-analysis system coupled with the Zeiss LSM laser scanning microscope. No positive staining was seen in controls.
Fos with NADPH-d. The double-labeling NADPH-d and Fos was performed using nitroblue tetrazolium formazan histochemical staining followed by Fos immunohistochemistry in the colonic LMMP whole mount preparation as previously described (57) . Briefly, LMMP whole mount preparations were rinsed (3 times for 10 min each) in phosphate buffer (PB; pH 7.4) and incubated for 30-60 min at 37°C in PB containing 0.3% Triton X-100, 0.5 mg/ml of ␤-NADPH, and 0.1 mg/ml of nitroblue tetrazolium. After a further rinsing (6 times for 20 min each) in PBS containing 0.3% Triton X-100 (pH 7.4), tissues were incubated for 48 h at 4°C with a polyclonal rabbit anti-Fos (fos Ab-5; 1:10,000) and processed using the standard biotin-avidin-horseradish peroxidase methodology (20) . Nickel was excluded from the chromogen (diaminobenzine) to discriminate NADPH-d staining from Fos immunoreactivity. NADPH-d activity was detected as dark blue formazan products into the nerve cell bodies, whereas Fos immunoreactivity was detected as brown nuclear staining. Tissues were examined using a light microscope (Nikon Labophot-2 Microscope, Melville, NY) and photographed (Kodak Ektachrome 64 T film).
Quantitative analysis. Monoclonal (TF161) and polyclonal (fos Ab-5) antibodies detect Fos protein in the myenteric ganglia (32) (33) (34) 49) . To avoid a possible discrepancy in the magnitude of Fos expression detected with TF161 and fos Ab-5, we blindly counted the number of Fos-positive nuclei stained only with the polyclonal antibody (fos Ab-5). In each rat, the number of Fos-IR cells as well as NADPH-d-positive neurons was counted in 25 myenteric ganglia randomly selected in each examined piece (0.25 cm 2 ) of the LMMP whole mount preparation and expressed as a mean number per myenteric ganglion. The mean number of Fos-immunoreactive (IR) cells per myenteric ganglion from each animal was used to generate a mean number for each experimental group.
Statistical analysis. Data are expressed as means Ϯ SE and analyzed by one-way ANOVA followed by Dunn's test to identify differences between individual treatment groups. The confidence limit for significance was set at P Ͻ 0.05.
RESULTS
Effects of Intraperitoneal CRF and CRF-Receptor Antagonists
There was a low number of in subcutaneous saline-pretreated rats was not modified by atropine (1 mg/kg sc; 15.0 Ϯ 1.9 Fos-IR cells/ ganglion, n ϭ 3). Photomicrographs illustrate the similar occurrence of Fos-IR induced by intraperitoneal CRF in the myenteric ganglia of rats pretreated subcutaneously either with vehicle (Fig. 4A) or atropine (Fig. 4B) .
Neuronal Identity of Fos-IR Cells in the Myenteric Ganglia
Double labeling of Fos with PGP 9.5. In rats injected intraperitoneally with water followed by saline, the proximal colon myenteric plexus displayed abundant ganglionic cells labeled with PGP 9.5, whereas a small number of Fos-IR nuclei was localized in PGP 9.5-IR cell bodies (Fig. 5A) . In rats pretreated with water, CRF (10 g/kg ip) induced Fos expression in the glanglionic myenteric neurons as illustrated by the double labeling of Fos/PGP 9.5 in all Fos-positive cells (Fig. 5B) .
Double labeling of Fos with VChAT or ChAT. The monoclonal Fos (TF161) was used for the double labeling. Proximal colonic tissues from rats injected intraperitoneally with saline showed abundant myenteric ganglionic nerve and varicose fibers immunoreactive to VChAT, whereas Fos immunoreactivity was rare or absent (Fig. 5C ). In contrast, proximal colonic tissues from rats injected with CRF (10 g/kg ip) exhibited ganglionic Fos-IR cells encircled by varicose fibers immunoreactive to VChAT (Fig. 5D) .
Colonic tissues from control rats injected intraperitoneally with saline and double labeled with Fos/ChAT did not show Fos-IR cells in the myenteric ganglia (Fig.  6A) . However, varicose fibers and a few nerve cell bodies immunoreactive to ChAT were visible in the myenteric ganglia where Fos IR was absent (Fig. 6, C  and D) . After intraperitoneal injection of CRF, there was abundant Fos-IR nuclei (Fig. 6B ), which were found in the majority of ChAT-IR nerve cell bodies surrounded by ChAT-IR varicose fibers (Fig. 6, D and F) .
Double labeling of Fos with NADPH-d.
In the colonic tissues from control rats pretreated with vehicle (intraperitoneal) and 15 min later with saline, the myenteric plexus displayed 9.2 Ϯ 0.4 NADPH-d-positive neurons/ganglion (n ϭ 3), whereas Fos-IR cells were absent (Fig. 7A) . A network of ganglionic NADPH-dpositive varicose fibers was also clearly visible. Occasionally NADPH-d-positive fibers arising from positive nerve cell bodies and traveling into the internodal strands were also visible in the myenteric plexus ( (Fig.  7C) . Similar results were observed with CP-154,526 (data not shown).
DISCUSSION
The present study demonstrates that CRF injected intraperitoneally in conscious rats induces Fos expression detected by immunohistochemistry in the myenteric plexus of the proximal colon 60 min after peptide administration. This response is specific to CRF, as shown by the rare Fos IR in the colonic myenteric plexus after the intraperitoneal injection of saline, whereas ϳ19 Fos-IR cells/ganglion were observed after intraperitoneal CRF. The double labeling of Fos with the neuronal marker PGP 9.5 (24) revealed the neuronal identity of activated myenteric cells. These data provide the first evidence of Fos expression in myenteric neurons of the proximal colon in response to the activation of CRF-signaling pathways established to be involved in colonic motor alterations induced by acute stress (7, 29, 56) . Fos expression has been extensively used to map, at the cellular level, stimuli-related activation of neuronal circuits in the central nervous system (25, 35) . This approach has also been successfully applied to the enteric nervous system embedded in the wall of stomach (5, 9, 34, 57) and small intestine (33, 40, 43, 45) . However, Fos induction in colonic myen- teric ganglia has received less attention, and investigations so far have been limited to the response of the distal colonic myenteric cells to acute experimental colitis (32, 49) .
The present findings indicate that intraperitoneal CRF-induced Fos expression in the proximal colonic myenteric neurons is CRF-receptor mediated. First, the specific CRF-receptor antagonist astressin, which displays equal high binding affinity to CRF 1 , and either splice variants of the CRF 2 receptors (41) injected peripherally abolished intraperitoneal CRF-induced Fos expression. Second, similar inhibition of CRF-induced ganglionic Fos expression was induced by the specific CRF 1 antagonist CP-154,526 (48) . We previously reported (29) that CRF (10 g/kg) injected intraperitoneally induced a new pattern of clustered spikeburst activity in the proximal colon and defecation, which were both antagonized by astressin and CP-154,526 at similar doses used in the present study. Together, these data support an important role of the CRF 1 receptor in the activation of myenteric neurons and propulsive motor activity in the proximal colon after peripheral administration of CRF.
The biochemical coding of CRF 1 -mediated Fos expression in myenteric neurons was investigated by immunohistochemical double-labeling techniques. With the use of a commercially available ChAT antibody (44), we visualized a few cell bodies immunoreactive to ChAT in the rat proximal colon, as reported in mice large intestine (44) . After intraperitoneal injection of CRF, all ganglionic ChAT-IR cells were Fos positive. We observed only a small proportion of ganglionic nerve cell bodies immunoreactive to ChAT, as previously described (44) . Recent studies (54) have reported the existence of ChAT mRNA splice variant that has been identified to be preferentially expressed in the peripheral nervous system (pChAT). With the use of an antibody raised against pChAT, 69% of total neuronal somata of myenteric ganglion in the rat colon were pChAT positive (37, 54) . The findings obtained with pChAT antibody indicate that cholinergic neurons comprise a major subpopulation of proximal and distal colonic myenteric neurons. This could also explain the small population of Fos-positive ganglionic cholinergic neurons observed in the present study using a ChAT antibody not directed to pChAT.
The detection of NADPH-d activity is a well-established cytochemical maker for the presence of NO synthase activity in myenteric neurons of the rat gut (4). We counted ϳ8-9 NADPH-d-positive neurons per myenteric ganglion in the LMMP whole mount preparations of rat proximal colon. These data are consistent with Takahashi and Owyang's previous study (53) Note that the images on the left (A, C, and E) or right (B, D, and F) panels were separately captured on the same longitudinal muscle/ myenteric plexus whole mount preparation of the rat proximal colon by using different filters on the Zeiss LSM laser scanning microscope. Tissues were examined 1 h after the intraperitoneal injection of CRF or saline.
gic neurons are differentially influenced by peripheral CRF.
The exact site(s) and mechanism(s) of intraperitoneal CRF action to induce CRF 1 -mediated Fos expression in the colonic myenteric neurons cannot be inferred from the present studies. Fos expression is induced in the guinea pig myenteric neurons as a consequence of activation of motor function (43) . Studies (19) performed in LMMP strips of guinea pig ileum established that the preferential CRF 1 agonist ovine CRF (51)-induced contractile response is blocked by atropine. In the present study, atropine injected peripherally at a dose (1 mg/kg) that prevented the CRF receptor-mediated colonic propulsive response to restraint stress (7) and basal contractile activity in the proximal colon (52) did not alter Fos expression induced by intraperitoneal CRF. Even a higher dose of atropine (2 mg/kg) resulted only in a small decrease in the number of Fos-positive cells (unpublished observations). Collectively these observations indicate that intraperitoneal CRF-induced Fos expression in the myenteric ganglia is unlikely to be secondary to muscarinic activation of colonic motor function.
Indirect evidence supports a possible site of action of CRF directly on myenteric neurons, although the distribution of CRF 1 receptors in rat enteric neurons of the colon is yet to be established. Indeed, an in vitro intracellular microelectrode recording study indicates that the preferential CRF 1 agonist ovine CRF (51) acts directly on both AH/type-2 and S/type-1 neurons in the LMMP from guinea pig ileum to evoke a prolonged excitatory response (16) , suggesting the presence of CRF 1 receptor on the enteric neurons. Alternatively, CRF may also influence preganglionic cholinergic input to myenteric neurons. Cholinergic nicotinic activation induces marked Fos expression in gastric myenteric neurons (34, 57) and excitation of myenteric neurons in the colon assessed electrophysiologically (6) . With the use of an antibody raised against VChAT to label terminal fields of the cholinergic nervous system (46), we found abundant VChAT-IR fiber bundles in the myenteric ganglia but rarely in cell bodies of rat proximal colon as previously reported (44) in mice. Abundant varicose fibers positive for ChAT were also detected in strands and around somata, suggesting a possible implication of the nicotinic cholinergic pathway(s). Fos-IR neurons induced by intraperitoneal CRF were encircled by varicose fibers immunoreactive to VChAT or ChAT, providing anatomical support for possible action of CRF to modulate cholinergic input to myenteric neurons expressing Fos. This will need to be further examined with the use of nicotinic blockade. However, any possible action of CRF presynaptically to increase cholinergic excitation of myenteric neurons would not be consistent with the lack of Fos induction in the NADPH-d-containing neurons. Indeed, nicotinic/ muscarinic-receptor activation is a major stimulus for gene transcription of NOS and NO release in the enteric nervous system (22, 38) . Other studies also showed that endogenous acetylcholine stimulates NOcontaining myenteric neurons in the gut, including the proximal colon (22, 57) . However, we could not exclude the possibility that CRF recruits enteric circuitry that inhibits cholinergic input to nitrinergic neurons.
The biochemical coding of activated myenteric neuron by intraperitoneal CRF may have a bearing with the increase in proximal colonic motility (29) . Cholinergic myenteric neurons play a major role in stimulating colonic motility in the proximal colon in various animal species, including the rat through muscarinic excitatory input to the muscles (12, 17) . The observed activation of cholinergic neurons, as evidenced by Fos expression, may contribute to the increased colonic contractile response to CRF, as observed in conscious rats (29) and in vitro colonic preparation (19, 29, 30) . The NO released from enteric neurons is well estab- Fig. 7 . Photomicrographs showing the double labeling of NADPH-diaphorase with Fos (fos Ab-5) in the longitudinal muscle/myenteric plexus whole mount preparation of the rat proximal colon. Rare or no Fos-IR cells but a consistent number of NADPH-diaphorase-positive nerve cell bodies (arrows) were detected in the myenteric ganglia of rats injected intraperitoneally with water followed 15 min later by saline (A). Ganglionic Fos-IR cells (brown stain) were labeled in tissues from rats pretreated with water (ip) followed 15 min later by CRF (10 g/kg ip; B). Fos IR (arrowheads) was in a population of ganglionic cells different to that showing NADPH-diaphorase activity (arrows; B). In rats pretreated intraperitoneally with astressin (33 g/kg) 15 min before CRF (10 g/kg), Fos-IR cells were rare, whereas an unchanged number of NADPH-diaphorase cells (arrows) was observed in the myenteric ganglia (C). Scale bar, 50 m.
lished to restrain basal and inhibit nerve-stimulated mechanical contractile activity in the proximal colon, whereby relaxation for mixing, storage of liquid feces, absorption, and propulsion are facilitated (26, 36, 38, 53) . The absence of simultaneous cholinergic and nitrinergic myenteric neuron activation observed in the present study may leave unopposed the excitatory cholinergic input to the proximal colonic smooth muscles induced by CRF.
In summary, data obtained in the present study show that CRF injected intraperitoneally induces Fos expression in proximal colon myenteric neurons through the activation of the CRF 1 receptor in conscious rats. CRF induced Fos expression in cholinergic myenteric neurons but not in a subpopulation of inhibitory neurons exhibiting NADPH-d activity. CRF action was not altered in the presence of atropine, indicating that ganglionic myenteric Fos induction is not secondary to the activation of muscarinic receptors either on the myenteric ganglia or colonic muscles (8, 12) . The CRF 1 -mediated activation of ganglionic neurons in the rat proximal colon by intraperitoneal CRF may have relevance to the neural mechanisms through which stress stimulates colonic propulsive motor function, as recently demonstrated in functional studies (29) .
